In this case study module, Sung-Bae Kim discusses key risk factors for disease recurrence in HR+/HER2- early breast cancer and outlines the prognostic tools that can be used for to help predict the risk for this, with reference to the disease course of a 34-year old HR+/HER2- early breast cancer patient.
After completing this activity, you will be able to:
- Describe the prognostic variables which can influence recurrence risk in HR+HER2- early breast cancer
- Explain the methods that can help determine prognosis and treatment efficacy
Sign up for new content alerts
Enter your email address below and we'll contact you as soon as new content is launched!